Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AGRONOMICS LIMITED Net Asset Value 2014

Jul 22, 2014

7474_rns_2014-07-22_6fb4a7cd-217f-46cd-868a-d917ded160ea.html

Net Asset Value

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9245M

Port Erin Biopharma Investments Ltd

22 July 2014

For immediate release                                                                                                                                 22 July 2014

Port Erin Biopharma Investments Limited

(the "Company")

Net Asset Value calculation to 30 June 2014

Jim Mellon, Chairman, commented: -

"The Net Asset Value ("NAV") calculation for the Company as at closing on 30 June 2014 was 14.71 pence per share, including un-invested cash of £526,503 and an accrual carried forward of £379,057 for the management fee. The portfolio is valued under IFRS at bid price.

Thus in the full year, Total Assets have grown in value by 37.1% to just under £5.0 million, and Investments have grown in value by 65.6% to £4.8 million. This quarter's NAV represents a decrease of 4.5% from the previous valuation of 15.40 pence per share, which included un-invested cash of £736,392. On this basis, no additional management fee is due to Shellbay Investments Limited.

Our holding in the Magna Biopharma Income Fund continues to perform well, the value having risen by 7.0% to £2.9 million in the six months since inception."

Unaudited

to 30 June 2014

£
Fixed Assets
Investments 4,830,908
Current Assets
Debtors: amounts owing 24,997
Un-invested cash 526,503
Current Liabilities
Creditors: amounts due (400,982)
4,981,426
Capital and Reserves
Share Capital 34
Share Premium 2,759,551
Current year's earnings 1,381,475
Retained earnings 840,366
4,981,426
Shares in Issue 33,864,836
Asset Value per share 14.71 pence

--- ENDS ---

Portfolio Details

Investments as at 30 June 2014 Value % of Total Portfolio
Magna Biopharma Income Fund £2,901,683 60.06%
Plethora Solutions Holdings £852,500 17.65%
Summit Corporation £536,667 11.11%
Other quoted holdings £163,938 3.39%
Other unquoted holdings £376,120 7.79%
Total £4,830,908 100.00%

For further information, please contact:

Port Erin Biopharma Investments Limited Beaumont Cornish Limited Peterhouse Capital Limited
The Company Nomad Broker
Denham Eke

+44 162 463 9396
Roland Cornish

+44 207 628 3396
Jon Levinson

+44 207 469 0935

This information is provided by RNS

The company news service from the London Stock Exchange

END

NAVGMGZNLMZGDZM